Coverage · what the dataset can prove
Coverage is the public checklist for evaluating a pack before purchase: exported records, active sources, field groups, workflow fit, and the caveats that limit interpretation.
Record coverage
The public counts below come from export-ready records and the source registry. They update with every snapshot cut instead of being hand-maintained in website copy.
Rows in the current dated release, with one row per openFDA product NDC.
Share of exported FDA product rows carrying the authoritative two-segment product NDC used as the release identity.
Share of exported FDA product rows associated with at least one DailyMed SPL set identifier.
Share of exported FDA product rows receiving active provenance from more than one contracted public source.
Share of exported FDA product rows with a served NDA, ANDA, BLA, or source marketing marker.
Share of exported FDA product rows with a latest-effective, source-linked NADAC per-unit value.
Maximum age 8 days. Oldest measured source refresh: 2026-09-16.
Weekly releases identify source dates. Product feeds, Drugs@FDA, and REMS use an eight-day bound; PMR/PMC, IID, and CMS SDUD use explicit 100-day bounds.
Field coverage
Schema groups come from the exported field model and curated field highlights. They are the default coverage map for filtering, joining, and reviewer audit work.
| group | fields | examples |
|---|---|---|
| Record identity | 6 | id, primary_source, source_id, source_record_url |
| Product names | 3 | brand_name, generic_name, manufacturer_name |
| Product form | 6 | dosage_form, route, strength, product_type |
| Regulatory status | 3 | marketing_status, dea_schedule, application_number |
| Classification | 3 | rxcui, atc_code, pharm_class |
| Provenance | 2 | _provenance, _sources |
| Shortage signals | 1 | shortages |
| Pricing | 2 | nadac_per_unit, pricing_unit |
| Recall signals | 2 | has_recall, recall_reason |
Source coverage
Source descriptions make coverage visible before a buyer logs into the portal or downloads the full snapshot.
State and national aggregate Medicaid utilization facts at utilization-type, exact NDC11, year, and quarter grain; suppressed measures remain null and reimbursement is not represented as price or coverage.
Structured Product Label titles, versions, and publication dates joined to the SPL set identifiers carried by FDA product records.
FDA application, product-number, submission, and document-metadata records delivered as separate auxiliary tables without claiming product-number-to-NDC applicability.
Quarterly FDA inactive-ingredient potency and maximum-daily-exposure facts delivered at ingredient/route/dosage-form grain; CAS Registry Numbers are excluded and product applicability is not asserted.
Workflow coverage
These use cases are the workflows this dataset is positioned to support. The same workflow set appears on the homepage, sample page, and agent-facing docs.
Find drug products
Search products by name or NDC code and inspect ingredients, dosage forms, and package identifiers.
Explore related records
Review linked label, RxNorm, and pricing records where available.
Find enforcement and shortage records
Inspect source-reported records linked to products by exact NDC identifiers.
Review data coverage
Check which products have related records and follow their source links.
Limits
Coverage claims should stay bounded by the manifest caveats and source licence terms.
- RxAtlas is reference data, not medical advice, prescribing advice or reimbursement advice.
- Buyers remain responsible for validating source terms and regulated use in their own workflow.
Related evaluation guides
Connect this diligence evidence to the relevant integration decision.